|Bid||38.50 x 1400|
|Ask||38.58 x 800|
|Day's range||38.53 - 39.06|
|52-week range||37.36 - 60.69|
|Beta (5Y monthly)||1.20|
|PE ratio (TTM)||24.56|
|Earnings date||24 Oct 2023 - 30 Oct 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||48.00|
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2023 Wells Fargo Healthcare Conference on September 6, 2023 at 1:30 p.m. EST. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations. About Integra LifeSci
Investors continue to be optimistic about Integra (IART) based on the prospects of its CSS segment and a stable liquidity position.